LAPIX THERAPEUTICS, INC.
🇺🇸United States
Clinical Trials
4
Active:1
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Phase 1
Active, not recruiting
- Conditions
- Atopic Dermatitis (AD)Psoriasis (PsO)
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-08-26
- Lead Sponsor
- LAPIX Therapeutics Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06982352
- Locations
- 🇺🇸
Red River Research Partners, Fargo, North Dakota, United States
Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
Phase 1
Recruiting
- Conditions
- Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- LAPIX Therapeutics Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06628206
- Locations
- 🇯🇴
Triumpharma Clinical Research Unit at AlEssra Hospital, Amman, Jordan
First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641
- First Posted Date
- 2023-05-11
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- LAPIX Therapeutics Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT05853835
- Locations
- 🇺🇸
AXIS Clinicals, Dilworth, Minnesota, United States
🇯🇴Triumpharma clinical research unit at Alessra Hospital, Amman, Jordan
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
Completed
- Conditions
- Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary Progressive
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- LAPIX Therapeutics Inc.
- Target Recruit Count
- 137
- Registration Number
- NCT05663853
- Locations
- 🇺🇸
The Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸MedStar Health, Chevy Chase, Maryland, United States
🇺🇸Corinne Goldsmith Dickinson Center for MS, New York, New York, United States
News
No news found